These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenström's macroglobulinemia after sequential treatment with chlorambucil and fludarabine. Shin SJ; Chun SH; Kim KO; Kim MK; Lee KH; Hyun MS; Cho HS Jpn J Clin Oncol; 2005 Oct; 35(10):622-5. PubMed ID: 16172172 [TBL] [Abstract][Full Text] [Related]
3. Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy. Kröger N; Hoffknecht M; Hänel M; Krüger W; Zeller W; Stockschläder M; de Wit M; Weh HJ; Kabisch H; Erttmann R; Zander AR Bone Marrow Transplant; 1998 Jun; 21(12):1171-5. PubMed ID: 9674847 [TBL] [Abstract][Full Text] [Related]
5. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460 [TBL] [Abstract][Full Text] [Related]
6. A case of Behćet's disease complicated by visceral Leishmaniasis and myelodysplasia: clinical considerations. Sirianni MC; Barbone B; Monarca B; Nanni M; Laganà B; Aiuti F Haematologica; 2001 Sep; 86(9):1004-5. PubMed ID: 11532637 [No Abstract] [Full Text] [Related]
7. Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation. Copelan EA; Penza SL; Elder PJ; Ezzone SA; Scholl MD; Bechtel TP; Belt PS; Avalos BR Bone Marrow Transplant; 2000 Jun; 25(12):1219-22. PubMed ID: 10871724 [TBL] [Abstract][Full Text] [Related]
8. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation. Del Cañizo Mf; Amigo Mf; Hernández JM; Sanz G; Núñez R; Carreras E; Alegre A; Cuesta B; Mataix R Haematologica; 2000 Apr; 85(4):403-9. PubMed ID: 10756367 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma. Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860 [TBL] [Abstract][Full Text] [Related]
10. Myelodysplasia and acute myeloid leukaemia in a case of rheumatoid arthritis with secondary amyloidosis treated with chlorambucil. Balakrishnan C; Pathan E; Khodaiji S; Dasgupta A; Mangat G; Joshi VR J Assoc Physicians India; 2004 May; 52():423-5. PubMed ID: 15656036 [TBL] [Abstract][Full Text] [Related]
11. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia. Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno NT; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson BS; Estey EH; Champlin R; Przepiorka D Am J Hematol; 2001 Aug; 67(4):227-33. PubMed ID: 11443634 [TBL] [Abstract][Full Text] [Related]
12. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence. Tarella C; Cuttica A; Vitolo U; Liberati M; Di Nicola M; Cortelazzo S; Rosato R; Rosanelli C; Di Renzo N; Musso M; Pavone E; Santini G; Pescarollo A; De Crescenzo A; Federico M; Gallamini A; Pregno P; Romano R; Coser P; Gallo E; Boccadoro M; Barbui T; Pileri A; Gianni AM; Levis A Cancer; 2003 Jun; 97(11):2748-59. PubMed ID: 12767087 [TBL] [Abstract][Full Text] [Related]
13. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2). Ogasawara T; Yasuyama M; Kawauchi K Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101 [TBL] [Abstract][Full Text] [Related]
14. [Myelodysplastic syndrome developed in a mother and her son whose bone marrow karyotype showed monosomy 7]. Wakita A; Komatsu H; Banno S; Ando M; Nitta M; Takada K; Mitomo Y; Ueda R Rinsho Ketsueki; 1996 Apr; 37(4):311-6. PubMed ID: 8847801 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic abnormalities and therapy-related myelodysplastic syndromes in rheumatic disease. McCarthy CJ; Sheldon S; Ross CW; McCune WJ Arthritis Rheum; 1998 Aug; 41(8):1493-6. PubMed ID: 9704650 [TBL] [Abstract][Full Text] [Related]
16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
17. Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma. Howe R; Micallef IN; Inwards DJ; Ansell SM; Dewald GW; Dispenzieri A; Gastineau DA; Gertz MA; Geyer SM; Hanson CA; Lacy MQ; Tefferi A; Litzow MR Bone Marrow Transplant; 2003 Aug; 32(3):317-24. PubMed ID: 12858205 [TBL] [Abstract][Full Text] [Related]
18. Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation. Sevilla J; Rodríguez A; Hernández-Maraver D; de Bustos G; Aguado J; Ojeda E; Arrieta R; Hernández-Navarro F Ann Hematol; 2002 Jan; 81(1):11-5. PubMed ID: 11807629 [TBL] [Abstract][Full Text] [Related]